CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Scientific Officer acquired 4,026 shares (option exercise)
- 4 Option exercise Director acquired 166,667 shares (option exercise)
- 4 Open-market sale Director sold 27,612,053 shares at an average $9.67 ($266,997,653)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 1,400,000 shares at an average $2.75 ($3,856,000)
- 4 Open-market sale Director sold 200,000 shares at $2.61 ($522,000)
- 4 Open-market sale Director sold 1,750,000 shares at an average $3.10 ($5,428,500)
- 4 Open-market sale Director sold 1,943,308 shares at an average $2.92 ($5,673,062)
- 4 Open-market sale Director sold 3,406,692 shares at an average $2.92 ($9,962,929)
- 4 Open-market sale Director sold 250,000 shares at an average $2.53 ($632,000)
- 4 Open-market sale Director sold 2,650,000 shares at an average $2.68 ($7,089,425)
Page 8 of 28 · 550 filings